Literature DB >> 3059338

Accuracy in the clinical diagnosis of parkinsonian syndromes.

W R Gibb1.   

Abstract

This review of Parkinson's disease and related disorders emphasizes the difficulties of distinguishing between variants of the parkinsonian syndrome. Characteristic clinical features may remain absent for many months, but accuracy of diagnosis may be improved by considering certain presenting symptoms and signs. The main characteristics of various parkinsonian syndromes are reviewed and their major distinguishing features are emphasized. Future improvement in the precision of clinical diagnosis, especially early in the course of parkinsonian syndromes, will depend on selecting out patients with Parkinson's disease using positive diagnostic criteria.

Entities:  

Mesh:

Year:  1988        PMID: 3059338      PMCID: PMC2428656          DOI: 10.1136/pgmj.64.751.345

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  45 in total

1.  Infections of the nervous system occurring during an epidemic of influenza B.

Authors:  A D LEIGH
Journal:  Br Med J       Date:  1946-12-21

2.  Primary sensory symptoms in parkinsonism.

Authors:  S R Snider; S Fahn; W P Isgreen; L J Cote
Journal:  Neurology       Date:  1976-05       Impact factor: 9.910

3.  Occult normal pressure hydrocephalus manifested by parkinsonism-dementia complex.

Authors:  G W Sypert; H Leffman; G A Ojemann
Journal:  Neurology       Date:  1973-03       Impact factor: 9.910

4.  Reversible Parkinson syndrome complicating postoperative hypoparathyroidism.

Authors:  J R Berger; D B Ross
Journal:  Neurology       Date:  1981-07       Impact factor: 9.910

Review 5.  Assessment of extrapyramidal disorders.

Authors:  C D Marsden; M Schachter
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

6.  Post-encephalitic Parkinsonism: current experience.

Authors:  D Rail; C Scholtz; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-08       Impact factor: 10.154

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

8.  Calcification of the basal ganglia: computerized tomography and clinical correlation.

Authors:  W C Koller; J W Cochran; H L Klawans
Journal:  Neurology       Date:  1979-03       Impact factor: 9.910

9.  Corticodentatonigral degeneration with neuronal achromasia.

Authors:  J J Rebeiz; E H Kolodny; E P Richardson
Journal:  Arch Neurol       Date:  1968-01

10.  Ocular manifestations in progressive supranuclear palsy.

Authors:  D D Pfaffenbach; D D Layton; T P Kearns
Journal:  Am J Ophthalmol       Date:  1972-12       Impact factor: 5.258

View more
  19 in total

Review 1.  Multiple system atrophy--the nature of the beast.

Authors:  N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

2.  Costs of illness in a Russian cohort of patients with Parkinson's disease.

Authors:  Yaroslav Winter; Sonja von Campenhausen; Georgy Popov; Jens P Reese; Jens Klotsche; Kai Bötzel; Eugene Gusev; Wolfgang H Oertel; Richard Dodel; Alla Guekht
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  Extrapyramidal signs should be sought more often in Alzheimer's disease.

Authors:  M N Lowenthal
Journal:  BMJ       Date:  1996-07-06

4.  Towards motor evaluation of Parkinson's Disease Patients using wearable inertial sensors.

Authors:  Vibha Anand; Erhan Bilal; Bryan Ho; John J Rice
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

5.  Cost of illness and its predictors for Parkinson's disease in Germany.

Authors:  Annika E Spottke; Martin Reuter; Olaf Machat; Bernhard Bornschein; Sonja von Campenhausen; Karin Berger; Rudolf Koehne-Volland; Jürgen Rieke; Alexander Simonow; Dirk Brandstaedter; Uwe Siebert; Wolfgang H Oertel; Gudrun Ulm; Richard Dodel
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

6.  MEG resting state functional connectivity in Parkinson's disease related dementia.

Authors:  J L W Bosboom; D Stoffers; E Ch Wolters; C J Stam; H W Berendse
Journal:  J Neural Transm (Vienna)       Date:  2008-11-04       Impact factor: 3.575

7.  Social and clinical determinants of quality of life in Parkinson's disease in Austria: a cohort study.

Authors:  Yaroslav Winter; Sonja von Campenhausen; Julia Gasser; Klaus Seppi; Jens-P Reese; Karl-P Pfeiffer; Kai Bötzel; Wolfgang H Oertel; Richard Dodel; Werner Poewe
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

8.  Effects of hemochromatosis and transferrin gene mutations on peripheral iron dyshomeostasis in mild cognitive impairment and Alzheimer's and Parkinson's diseases.

Authors:  S Mariani; M Ventriglia; I Simonelli; G Spalletta; S Bucossi; M Siotto; F Assogna; J M Melgari; F Vernieri; R Squitti
Journal:  Front Aging Neurosci       Date:  2013-08-05       Impact factor: 5.750

9.  Elevated levels of α-synuclein oligomer in the cerebrospinal fluid of drug-naïve patients with Parkinson's disease.

Authors:  Min Jeong Park; Sang-Myung Cheon; Hye-Ran Bae; Sang-Ho Kim; Jae Woo Kim
Journal:  J Clin Neurol       Date:  2011-12-29       Impact factor: 3.077

10.  Effect of educational intervention on medication timing in Parkinson's disease: a randomized controlled trial.

Authors:  Katherine A Grosset; Donald G Grosset
Journal:  BMC Neurol       Date:  2007-07-16       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.